GZA Hospitals Campus Sint- Augustinus

Wilrijk 2610

0 studies enrolling now · 2 studies all time

What they study most

HER2-Positive Primary Breast Cancer, Residual Invasive Breast Cancer, Squamous Cell Carcinoma of the Head and Neck

Studies at this site

• A Study of Trastuzumab Deruxtecan (T-DXd) Versus Trastuzumab Emtansine (T-DM1) in High-risk HER2-positive Participants With Residual Invasive Breast Cancer Following Neoadjuvant Therapy (DESTINY-Breast05) — Running, not enrolling
• Study To Compare Avelumab In Combination With Standard of Care Chemoradiotherapy (SoC CRT) Versus SoC CRT for Definitive Treatment In Patients With Locally Advanced Squamous Cell Carcinoma Of The Head And Neck (JAVELIN HEAD AND NECK 100) — Stopped early